milrinone has been researched along with glycogen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, KM; Hargrove, DM; Nardone, NA; Parker, JC; VanVolkenburg, MA | 1 |
Boden, G; Cheung, P; Yang, G | 1 |
2 other study(ies) available for milrinone and glycogen
Article | Year |
---|---|
Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipocytes; Animals; Blood Glucose; Glucose Tolerance Test; Glycerol; Glycogen; Insulin; Insulin Secretion; Isoenzymes; Male; Mice; Mice, Obese; Milrinone; Obesity; Phosphodiesterase Inhibitors; Pyridones | 1997 |
Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Actins; Adipose Tissue; Animals; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Glucose; Glucose Clamp Technique; Glycogen; Hyperinsulinism; Hypoglycemic Agents; Insulin; Lipolysis; Liver; Male; Milrinone; Muscle, Skeletal; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2003 |